no statement of use filed
on 10 Jun 2024
Last Applicant/ Owned by
Songshan Dist.
Taipei City
TW
10595
Serial Number
97820853 filed on 02th Mar 2023
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations and substances for the treatment of ophthalmic diseases and disorders; Pharmaceuticals preparations and substances for the treatment of inflammation and pain; Pharmaceutical preparations and substances for the treatment of ophthalmological and ocular diseases and disorders; Ophthalmic preparations; Pharmaceutical preparations, namely, a topical preparation for the treat Read More
Pharmaceutical preparations and substances for the treatment of ophthalmic diseases and disorders; Pharmaceuticals preparations and substances for the treatment of inflammation and pain; Pharmaceutical preparations and substances for the treatment of ophthalmological and ocular diseases and disorders; Ophthalmic preparations; Pharmaceutical preparations, namely, a topical preparation for the treatment of ophthalmic diseases and disorders, a topical preparation for the treatment of EYE INFLAMMATION AND PAIN, a topical preparation for the treatment of POSTOPERATIVE surgeries in CATARACTS, a topical preparation for the treatment of postoperative surgeries; Pharmaceutical preparations for the treatment of eye diseases and conditions
N/A
N/A
No 97820853
No Service/Collective Mark
No IPI018US50
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
12th Jul 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
10th Jun 2024 | ABANDONMENT - NO USE STATEMENT FILED |
07th Nov 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
12th Sep 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
12th Sep 2023 | PUBLISHED FOR OPPOSITION |
23rd Aug 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
04th Aug 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
02th Aug 2023 | ASSIGNED TO EXAMINER |
22nd Mar 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
06th Mar 2023 | NEW APPLICATION ENTERED |